Hjem › Multipelt myelom › California › Baldwin Park
Kliniske studier for Multipelt myelom i Baldwin Park, CA
23 studier for Multipelt myelom søker deltakere på steder i og rundt Baldwin Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1
- City of Hope National Medical Center /ID# 280273, Duarte · 4 mi unna
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
RekruttererFase 1/2
- City of Hope National Medical Center, Duarte · 4 mi unna
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
RekruttererFase 1
- Research Site, Duarte · 4 mi unna
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- City of Hope Duarte, Duarte · 4 mi unna
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi unna
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- City of Hope - Duarte, Duarte · 4 mi unna
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- City of Hope Duarte, Duarte · 4 mi unna
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RekruttererFase 4
- City of Hope, Duarte · 4 mi unna
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
RekruttererFase 3
- City of Hope National Medical Center, Duarte · 4 mi unna
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- Research Site, Duarte · 4 mi unna
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekruttererFase 1/2
- Research Site, Duarte · 4 mi unna
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi unna
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruttererFase 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · 4 mi unna
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Rekrutterer
- City of Hope, Duarte · 4 mi unna
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi unna
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- City of Hope Medical Center, Duarte · 4 mi unna
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- City of Hope, Duarte · 4 mi unna
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Chicago, IL22 studier
- Seattle, WA22 studier
Andre studier i Baldwin Park
- Brystkreft45 studier
- Akut myelogen leukemi40 studier
- Kolorektal kreft38 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)33 studier
- Prostatakreft30 studier
- Metastatisk kreft30 studier
- Myelodysplastiske syndromer26 studier
- Eggstokkreft25 studier
- Lungekreft24 studier
- Mavekreft22 studier
- Akut lymfoblastisk leukemi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.